Fulcrum downgraded after setback for lead program (replace) Source: Seekingalpha
Browsing: program
Fulcrum downgraded after setback for lead program (replace) Source: Seekingalpha
Immunovant stock falls 8% amid Graves’ disease program update Source: Seekingalpha
Immunovant stock falls 8% amid Graves’ disease program update Source: Seekingalpha
Immunovant stock falls 8% amid Graves’ disease program update Source: Seekingalpha
designer491/iStock by way of Getty Images Immunovant (NASDAQ:IMVT) stock fell 8% Monday after it reported knowledge from a Phase 2a research of batoclimab within the therapy…
Sundry Photography/iStock Editorial by way of Getty Images Healthcare suppliers are up in arms towards Johnson & Johnson (NYSE:JNJ) after the pharma big, on Friday, considerably…
Sundry Photography/iStock Editorial by way of Getty Images Healthcare suppliers are up in arms in opposition to Johnson & Johnson (NYSE:JNJ) after the pharma large, on…
Sundry Photography/iStock Editorial through Getty Images Healthcare suppliers are up in arms in opposition to Johnson & Johnson (NYSE:JNJ) after the pharma big, on Friday, considerably…
Sundry Photography/iStock Editorial by way of Getty Images Healthcare suppliers are up in arms towards Johnson & Johnson (NYSE:JNJ) after the pharma large, on Friday, considerably…